Zobrazeno 1 - 10
of 168
pro vyhledávání: '"Chao Yie Yang"'
Autor:
Jaymeson Gordon, Carlos Bravo-Perez, Luca Guarnera, Serhan Unlu, Naomi Kawashima, Arooj Ahmed, Christopher Haddad, Yasuo Kubota, Ishani Nautiyal, Fauzia Ullah, Danai Dima, Nakisha D. Williams, Tariq Kewan, Waled Bahaj, Hetty E. Carraway, Chao-Yie Yang, Carmelo Gurnari, Valeria Visconte, Jaroslaw P. Maciejewski
Publikováno v:
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-4 (2024)
Externí odkaz:
https://doaj.org/article/5ac3055fb4da4ce3afb8ec78e891a1df
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Externí odkaz:
https://doaj.org/article/84aa8a1b1a194988a4a8fab6c306b74d
Autor:
Haibin Zhou, Jianfeng Lu, Krishnapriya Chinnaswamy, Jeanne A. Stuckey, Liu Liu, Donna McEachern, Chao-Yie Yang, Denzil Bernard, Hong Shen, Liangyou Rui, Yi Sun, Shaomeng Wang
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-13 (2021)
Activation of cullin-RING ligases can be inhibited by targeting DCN1, but selective DCN1 inhibitors with in vivo activity are lacking. Here, the authors develop covalent DCN1 inhibitors that selectively and potently inhibit cullin-3 activation and do
Externí odkaz:
https://doaj.org/article/f1b1354b41f3482fb5e78275ffe16f27
Autor:
Xinrui Yuan, Kathryn L. Howie, Mona Kazemi Sabzvar, Krishnapriya Chinnaswamy, Jeanne A. Stuckey, Chao-Yie Yang
Publikováno v:
ACS Medicinal Chemistry Letters. 14:450-457
Autor:
Madison N. Sluter, Rajib Bhuniya, Xinrui Yuan, Andhavaram Ramaraju, Yu Chen, Ying Yu, Keyur R. Parmar, Zaid H. Temrikar, Ashish Srivastava, Bernd Meibohm, Jianxiong Jiang, Chao-Yie Yang
Publikováno v:
ACS Pharmacology & Translational Science. 6:587-599
Autor:
Haibin Zhou, Jianfeng Lu, Liu Liu, Denzil Bernard, Chao-Yie Yang, Ester Fernandez-Salas, Krishnapriya Chinnaswamy, Stephanie Layton, Jeanne Stuckey, Qing Yu, Weihua Zhou, Zhenqiang Pan, Yi Sun, Shaomeng Wang
Publikováno v:
Nature Communications, Vol 8, Iss 1, Pp 1-12 (2017)
Cullins are central components of the ubiquitin-proteosome system and are activated via a neddylation process mediated by the DCN1–UBC12 complex. Here, the authors develop a small molecule inhibitor of the DCN1–UBC12 interaction that specifically
Externí odkaz:
https://doaj.org/article/a1e0427493d44f3fa81a56f36c37a6f4
Autor:
Yifan Zhai, Asher Chanan-Khan, Shaomeng Wang, Dajun Yang, Sikander Ailawadhi, Anthony Letai, Jeremy Ryan, Caixia Li, Depei Wu, Jeanne A. Stuckey, Chao-Yie Yang, Sally Przybranowski, Donna McEachern, Mi Wang, Liu Liu, Longchuan Bai, Bing Han, James Miller, John A. Copland, Gina Ciccio, Nabanita Halder, Navnita Dutta, Yan Yin, Ping Min, Jianyong Chen, Saijie Zhu, Hengbang Wang, Guangfeng Wang, Alak Manna, Douglas D. Fang, Aneel Paulus, Jing Deng
Supplementary Tables from Lisaftoclax (APG-2575) Is a Novel BCL-2 Inhibitor with Robust Antitumor Activity in Preclinical Models of Hematologic Malignancy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93cc29265231a5604031f426cd989d83
https://doi.org/10.1158/1078-0432.22489368.v1
https://doi.org/10.1158/1078-0432.22489368.v1
Autor:
Yifan Zhai, Asher Chanan-Khan, Shaomeng Wang, Dajun Yang, Sikander Ailawadhi, Anthony Letai, Jeremy Ryan, Caixia Li, Depei Wu, Jeanne A. Stuckey, Chao-Yie Yang, Sally Przybranowski, Donna McEachern, Mi Wang, Liu Liu, Longchuan Bai, Bing Han, James Miller, John A. Copland, Gina Ciccio, Nabanita Halder, Navnita Dutta, Yan Yin, Ping Min, Jianyong Chen, Saijie Zhu, Hengbang Wang, Guangfeng Wang, Alak Manna, Douglas D. Fang, Aneel Paulus, Jing Deng
Supplementary Figures from Lisaftoclax (APG-2575) Is a Novel BCL-2 Inhibitor with Robust Antitumor Activity in Preclinical Models of Hematologic Malignancy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee10d364e50997d25d9fc8b6127afe2e
https://doi.org/10.1158/1078-0432.22489371.v1
https://doi.org/10.1158/1078-0432.22489371.v1
Autor:
Shaomeng Wang, Matthew J. Ellis, Shunqiang Li, Daniel F. Hayes, Jeanne Stuckey, Jennifer Meagher, Duxin Sun, Bo Wen, Yali Dou, Jing Xu, Ester Fernandez-Salas, Liu Liu, Yujun Zhao, Fuming Xu, Jiantao Hu, Hui Jiang, Sally Przybranowski, Donna McEachern, Jiao Ji, Chao-Yie Yang, Bing Zhou, Longchuan Bai
This file contains supporting information of methods including compound syntheses, molecular modeling, reagents, proteomic & transcriptome profiling and QPCR primers.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::acaf9c1512031e7d5f24787edc6c376f
https://doi.org/10.1158/0008-5472.22416459.v1
https://doi.org/10.1158/0008-5472.22416459.v1
Autor:
Shaomeng Wang, Matthew J. Ellis, Shunqiang Li, Daniel F. Hayes, Jeanne Stuckey, Jennifer Meagher, Duxin Sun, Bo Wen, Yali Dou, Jing Xu, Ester Fernandez-Salas, Liu Liu, Yujun Zhao, Fuming Xu, Jiantao Hu, Hui Jiang, Sally Przybranowski, Donna McEachern, Jiao Ji, Chao-Yie Yang, Bing Zhou, Longchuan Bai
Triple-negative breast cancers (TNBC) remain clinically challenging with a lack of options for targeted therapy. In this study, we report the development of a second-generation BET protein degrader, BETd-246, which exhibits superior selectivity, pote
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7940a8cd3bd8a9c044fa0c2e9e104c31
https://doi.org/10.1158/0008-5472.c.6509556.v1
https://doi.org/10.1158/0008-5472.c.6509556.v1